Cases 1 - 10 of 1,005
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00036
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
City of Martinsville, Virginia v. Purdue Pharma, L.P. et al
as 4:2024cv00002
Plaintiff:
City of Martinsville, Virginia
Defendant:
Purdue Pharma, L.P., Purdue Pharma, Inc., The Purdue Frederick Company, Inc. and others
Cause Of Action: 28 U.S.C. § 1446 pl Petition for Removal - Product Liability
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2023cv00088
Plaintiff:
Actelion Pharmaceuticals Ltd. and Actelion Pharmaceuticals US, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant:
Abraxis Bioscience, LLC
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff:
Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Burgess v. Rugby Laboratories, Inc. et al
as 3:2022cv00658
Plaintiff:
Albert C. Burgess, Jr.
Defendant:
Rugby Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00114
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00085
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2022cv00061
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
